SOPHARMA AD: PRELIMINARY INDIVIDUAL FINANCIAL STATEMENTS FOR 2017

opublikowano: 2018-01-30 14:36

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
3JR_Preliminary_FS_2017.zip  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 5 / 2018
Date of issue: 2018-01-30
Short name of the issuer
SOPHARMA AD
Subject
PRELIMINARY INDIVIDUAL FINANCIAL STATEMENTS FOR 2017
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
PRELIMINARY INDIVIDUAL FINANCIAL STATEMENTS FOR 2017

1. Financial Statements
2. Notes to the Financial Statements
3. Management report
4. Templates of the financial reports approved by the Bulgarian FSC
5. Declaration of the responsible directors
6. Insiders' information
7. Additional information
8. List of insider information under Art. 7 of Regulation (EU) 596/2014
9. Results for 2017
Annexes
File Description
3JR_Preliminary_FS_2017.zip3JR_Preliminary_FS_2017.zip PRELIMINARY INDIVIDUAL FINANCIAL STATEMENTS FOR 2017

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2018-01-30 Ognian Donev Executive director